Here in this study regarding the over expression of tp, which causes some physical, mental and socio problems like psoriasis, chronic inflammatory disease, tumor angiogenesis and rheumatoid arthritis etc. By this consideration, the inhibition of this enzyme is vital to secure life from serious threats. in connection with this, we have synthesized twenty derivatives of isoquinoline bearing oxadiazole (1-20), characterized through different spectroscopic techniques such as HREI-MS, 1 H-nMR and 13 c-nMR and evaluated for thymidine phosphorylase inhibition. All analogues showed outstanding inhibitory potential ranging in between 1.10 ± 0.05 to 54.60 ± 1.50 µM. 7-Deazaxanthine (IC 50 = 38.68 ± 1.12 µM) was used as a positive control. through limited structure activity relationships study, it has been observed that the difference in inhibitory activities of screened analogs are mainly affected by different substitutions on phenyl ring. The effective binding interactions of the most active analogs were confirmed through docking study.
Results and Discussion
chemistry. Methyl the intermediate product (V) was treated with different benzaldehyde/acetophenone in 20 ml methanol in the presence of acetic acid and refluxed for 4 hrs to give isoquinoline bearing oxadiazole (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) as final product ( Fig. 3 , Table 1 ). The final product was washed with ethanol/hexane in order to obtain pure products. All analogues (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) of this compound library were elucidated by spectroscopic techniques like 1H-NMR, 13C-NMR and HREI-MS.
In vitro thymidine phosphorylase activity. Twenty analogues (1-20) of isoquinoline bearing oxadiazole
were synthesized and evaluated as inhibiter against thymidine phosphorylase enzyme. All analogs of the entire series were found with most potent inhibitory potential with IC 50 values ranging in between 1.10 ± 0.05 µM to 54.60 ± 1.50 µM under positive control of reference drug 7-Deazaxanthine (IC 50 = 38.68 ± 1.12 µM). Seventeen analogues such as analogue 1-14 and 16-18 showed excellent inhibitory potential more better than the standard while three analogue 2, 15 and 19 showed good inhibitory activity. SAR study for thymidine phosphorylase inhibitory activity (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . The SAR study for particular analog among the series is mainly focused via the substitution on phenyl ring. Here in this study it was found that change of substituion or their swithing from one position to other postion on phenyl ring greatly effects the inhibitory appitude of analogues and these effects are summaraized in the below paragraphs.
If we compare analogue 15 (IC 50 = 47.30 ± 1.20 µM) having three methoxy groups at 2,3,4-position on phenyl ring with analogue 19 (IC 50 = 54.60 ± 1.50 µM) also having three methoxy groups on phenyl ring at 3,4,5-positions. Both analogues have the identical number of methoxy group on phenyl ring. The only difference found in their structures is the position of substituents on phenyl ring. With argue that substitution of methoxy groups on phenyl ring at 2,3,4-positions might activates the phenyl ring towards active of enzyme and therefore analogues 15 exhibited good activity profile than that of analogue 19 (Fig. S1 ).
It was seeming from the inhibitory activities that the position of substituents on phenyl ring greatly effects the inhibitory ability of the analogs. Therefore analogs 12, 13 and 18 (IC 50 = 4.60 ± 0.10 µM, 6.00 ± 0.20 µM and 7.30 ± 0.20 µM) all have the same hydroxyl and methoxy groups on phenyl ring at various positions but analog 12 have hydroxyl and methoxy groups at 3, 4 positions who exhibited superior inhibitory activity then analogs 13 and 18 respectively. It clearly indicates that the position of substituents on phenyl ring might play some basic role in binding interactions of ligands and active site of enzyme ( Fig. S2 ).
It was also shown via SAR study that some time the inhibitory activity of analog was also increased by increasing the extent of identical substituents on phenyl ring. On this regard analog 3 (IC 50 = 3.30 ± 0.10 µM) with two chlorine atom at 2, 4 positions on phenyl ring displayed many fold better inhibitory activity then analog 6 (IC 50 = 16.40 ± 0.50 µM) bearing one more chlorine atom on phenyl ring at 4 position ( Fig. S3 ).
Here in this study, it was clearly indicated that both electron donating group (EDG) and electron withdrawing group (EWG) on phenyl ring in all analog among the series displayed inhibitory activity. The slight difference in their potentials of analogs was mainly due to the position of substituent as well as the extent of substituent on Table S1 . The chemistry of substituents and the structural feature of most active analogs shown its efficiency in inhibitions like NH 2 group have electron donating effect and certain electronegative groups i.e halogen, methoxy and OH groups. Among the docked analogs chlorine containing analogs were shown superior inhibition than Br supported by methoxy group. The interaction modes among the docked conformation of utmost analogs are demonstrated in Fig. 4(a,b) . After docking, the docking conformation obtained was found with good docking score and show good result in-silico study, regarding thymidine phosphorylase enzyme inhibition. Rationally the biological evaluation and docking study of all analogs displayed good correlation result ( Fig. 5 ). (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . In some cases, precipitate formation was taken place within the solution which was directly filtered to obtain pure analogues. Furthermore, in case of aldehydes/acetophenone having hydroxyl/methoxy substituents, the reaction mixture was dried openly in Petridish/china-dish and then followed by workup with hexane/methanol system to obtain pure analogues. N'-(anthracen-9-ylmethylene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl) N'-(2,4-dichlorobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl) 5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(4-(phenoxymethyl) N'-(4-chlorobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl) N'-(5-bromo-2-methoxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl) benzohydrazide (7) . Yield N'-(4-(dimethylamino)benzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl) N'-(3,5-dichloro-2-hydroxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl N'-(3-aminobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl) (20) . Yield Assay protocol for thyimidine phosphorylase. The desired activity of thymidine phosphorylase under this protocol was carried out with slight modification in the method described by Krenitsky and Bush in 1979 46, 47 . Here, TP activity was determined through spectrophotometrically by absorbance at 290 nm. Although the whole reaction mixture of 200 µL have the limit of 145 µL of potassium phosphate buffer (pH 7.4, 50 mM), 30 µL of enzyme (human and E. coli) by concentration 0.05 and 0.002 U, distinectly, followed by incubation through 5 µL of test materials (0.075, 0.15, 0.3 and 0.5 mM) at 25 °C for 10 min in triplet reader. Subsequently, pre-read at 290 nm was taken to conclude the absorbance of concern substrate particles. The crave substrate "thyimidin" (20 µL, 1.5 mM), was then dissolved in the buffer (potassium phosphate), followed by instant addition to plate with constant read after every 10, 20 and 30 min in micro plate reader (spectra max, molecular devices, CA, USA). All the assay were implemented in triplicate under positive control of 7-Deazxanthine.
4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(2-nitrobenzylidene)benzohydrazide (1). Yield: 80%,

4-(
4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(1-(4-nitrophenyl)ethylidene)benzohydrazide (5). Yield
4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(2,3,4-trihydroxybenzylidene)benzohydrazide
Molecular docking. The interactions between target and inhibitors were investigated through molecular docking 48 . Molecular docking was carried out through MOE-Dock program (www.chemcomp.com) to find the interactions between synthesized analogs and ligand proteins. From Protein Databank (PDB), three dimensional structures (3D) of thymidine phosphorylase (4EAD) was retrieved. In MOE (www.chemcomp.com) the synthesized analogs were docked into the active site of the target docked enzyme by applying the default parameter i-e Rescoring 1: London dG, Refinement: Forcefield (MMFF94x), Placement: Triangle Matcher, London dG: Rescoring 2. Ten conformations were generated for each in which the conformation of the top ranked based on docking score was selected for additional studies in molecular docking. The best pose here having polar, Pi-H and H-Pi interactions were analyzed by Pymol software after molecular docking.
